Nasal Drop Therapy for ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a nasal drop made from tiny cell particles (extracellular vesicles) for ALS. The goal is to see if it's safe and if it can slow down the disease. It may be an option if your ALS is in the early to moderate stage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You should have had ALS symptoms for 6 months to 2 years.
- Your ALS must be diagnosed as "Definite," "Probable," or "Possible" ALS.
- You need a breathing test score (FVC) of 70% or higher.
- You cannot have serious nose problems, low blood counts, or certain infections.
- If you take riluzole or edaravone, the dose must have been the same for at least 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nasal drop made from stem cell components. It may act directly in the brain to help slow or treat several conditions like Alzheimer's, Parkinson's, multiple system atrophy, dementia with Lewy bodies, or frontotemporal dementia.
This trial tests whether injecting neural stem cells into the spine can slow down ALS. It is for people with rapidly progressing ALS who have good lung function and a caregiver to help with visits.
This trial tests a new stem cell treatment called NurOwn for people with early-stage ALS. It aims to slow down the disease and improve quality of life.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests whether a new medicine, made of tiny capsules containing a protein called nerve growth factor, can help people with ALS. It aims to see if the treatment can slow the disease and improve symptoms.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.